VIATRIS MASTERCLASS 2024 - EMERGING ASIA MEDICAL AFFAIRS (August 3rd & 4th, 2024 | Da Nang, Vietnam)

Viatris, in collaboration with the Vietnam National Heart Association (VNHA) and Vietnam Rheumatology Association (VRA), successfully hosted the Viatris Masterclass 2024 in Da Nang, Viet Nam on August 3rd and 4th. As part of Viatris’ commitment to education in Southeast Asia, the Masterclass offered a platform for healthcare professionals (HCPs) to build their capabilities, and pain management.

 

According to Dr. Nagendra Ramanjinappa, Head of Medical Affairs Asia and SSA at Viatris, such medical educational events would provide a valuable opportunity for HCPs in networking, knowledge sharing, and collaboration, ultimately leading to positive changes and better patient outcomes. He also emphasized the importance of HCPs and stakeholders working together to improve patient care in these two escalating disease burden.¹

 

Viatris is a global healthcare company positioned to bridge the traditional divide between generics and brands, combining the best of both to more holistically address healthcare needs globally. With a mission to empower people worldwide to live healthier at every stage of life, the company provides access at scale, currently supplying high-quality medicines to approximately 1 billion patients around the world annually.²

 

In Vietnam, Viatris’ portfolio encompasses areas such as cardiovascular disease (CVD), pain, the central nervous system, and men’s health. The company is committed to localization efforts through technology transfer, ensuring access to essential medications for Vietnamese patients.³